Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer
- PMID: 18446142
- DOI: 10.1038/ncponc1128
Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer
Comment on
-
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.Ann Oncol. 2007 Oct;18(10):1652-9. doi: 10.1093/annonc/mdm283. Epub 2007 Jul 28. Ann Oncol. 2007. PMID: 17660491
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources